Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.14%3.64B | 28.28%1.08B | 23.05%758M | -9.10%759M | 12.77%1.04B | 62.87%3.22B | 49.56%845M | 123.19%616M | 154.57%835M | 14.36%924M |
Net income from continuing operations | 0.50%1.4B | -30.31%292M | 43.67%477M | 60.20%322M | -29.66%313M | 28.99%1.4B | 58.11%419M | -14.21%332M | 443.24%201M | 12.94%445M |
Operating gains losses | -400.00%-15M | 425.00%21M | -175.00%-11M | -3,400.00%-33M | 300.00%8M | -121.43%-3M | 500.00%4M | -180.00%-4M | 200.00%1M | -136.36%-4M |
Depreciation and amortization | 6.22%1.33B | -36.23%44M | 11.80%417M | 4.92%448M | 9.87%423M | 7.73%1.25B | -2.82%69M | 4.19%373M | 13.26%427M | 7.54%385M |
Deferred tax | 7.18%194M | 187.10%178M | -474.19%-116M | 202.78%109M | -55.77%23M | 311.36%181M | 113.79%62M | 106.67%31M | 300.00%36M | 188.89%52M |
Other non cash items | 0.62%325M | 10.77%401M | -84.21%3M | -23.81%-52M | -68.75%-27M | -22.91%323M | -24.11%362M | 2,000.00%19M | -68.00%-42M | 50.00%-16M |
Change In working capital | 515.38%400M | 307.04%147M | 91.18%-12M | -117.54%-37M | 395.08%302M | 108.66%65M | 74.28%-71M | 72.19%-136M | 579.55%211M | 5.17%61M |
-Change in receivables | -110.05%-40M | 0.93%-214M | 292.96%137M | -167.84%-135M | -64.61%172M | 213.07%398M | -6.93%-216M | -139.89%-71M | 157.51%199M | 2,600.00%486M |
-Change in inventory | -73.64%-191M | 143.33%146M | -32.75%-227M | 11.36%-117M | -94.74%7M | -12.24%-110M | -43.40%60M | 17.39%-171M | -4.76%-132M | 3.10%133M |
-Change in payables and accrued expense | 114.71%45M | 1.52%134M | -96.15%2M | 223.94%88M | 57.28%-179M | -380.73%-306M | 210.92%132M | 138.52%52M | -117.53%-71M | -897.62%-419M |
-Change in other current liabilities | ---- | ---- | ---- | 15.25%-50M | -10.00%90M | ---- | ---- | ---- | -78.79%-59M | -7.41%100M |
-Change in other working capital | 606.02%586M | 272.34%81M | 22.11%116M | -35.40%177M | 188.70%212M | 120.24%83M | 22.95%-47M | 138.00%95M | 389.29%274M | -54.19%-239M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 13.14%3.64B | 28.28%1.08B | 23.05%758M | -9.10%759M | 12.77%1.04B | 62.87%3.22B | 49.56%845M | 123.19%616M | 154.57%835M | 14.36%924M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -20.90%-4.95B | 79.38%-238M | -20.96%-1.19B | -95.29%-1.91B | -64.73%-1.62B | -19.35%-4.1B | -18.00%-1.15B | -11.07%-983M | -24.30%-977M | -25.45%-981M |
Capital expenditure reported | -13.55%-4.47B | -11.24%-1.25B | -20.38%-1.13B | -10.86%-1.04B | -12.17%-1.05B | -16.46%-3.93B | -14.27%-1.12B | -8.20%-937M | -22.43%-939M | -22.64%-937M |
Net business purchase and sale | 0.00%-27M | ---23M | --0 | 91.67%-1M | 70.00%-3M | -107.69%-27M | --0 | 0.00%-5M | -100.00%-12M | -900.00%-10M |
Net investment purchase and sale | -233.33%-4M | --1.05B | 200.00%1M | -14,283.33%-851M | -10,000.00%-202M | 200.00%3M | --0 | ---1M | 700.00%6M | 0.00%-2M |
Net other investing changes | -198.15%-483M | 38.10%-26M | -43.18%-63M | 22.50%-31M | -908.33%-363M | -184.21%-162M | -740.00%-42M | -193.33%-44M | -100.00%-40M | -111.76%-36M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -20.90%-4.95B | 79.38%-238M | -20.96%-1.19B | -95.29%-1.91B | -64.73%-1.62B | -19.35%-4.1B | -18.00%-1.15B | -11.07%-983M | -24.30%-977M | -25.45%-981M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 52.32%1.35B | -705.78%-1.78B | 248.72%1.37B | 1,828.26%887M | 477.48%872M | -39.60%883M | -27.41%294M | -32.18%392M | -88.02%46M | 58.95%151M |
Net issuance payments of debt | 30.26%2.18B | -425.15%-1.58B | 168.31%1.58B | 343.90%1.09B | 207.34%1.09B | 69.23%1.67B | 168.99%485M | -23.27%587M | -56.92%246M | -0.28%354M |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash dividends paid | -7.71%-810M | -7.98%-203M | -7.98%-203M | -7.45%-202M | -7.45%-202M | -9.78%-752M | -9.94%-188M | -9.30%-188M | -9.94%-188M | -9.94%-188M |
Net other financing activities | 37.84%-23M | 66.67%-1M | 28.57%-5M | 75.00%-3M | 6.67%-14M | 56.98%-37M | 85.71%-3M | 53.33%-7M | 25.00%-12M | 55.88%-15M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 52.32%1.35B | -705.78%-1.78B | 248.72%1.37B | 1,828.26%887M | 477.48%872M | -39.60%883M | -27.41%294M | -32.18%392M | -88.02%46M | 58.95%151M |
Net cash flow | ||||||||||
Beginning cash position | 18.60%51M | 1,450.00%1.02B | 112.20%87M | 154.74%349M | 18.60%51M | 22.86%43M | 29.41%66M | -50.00%41M | -12.18%137M | 22.86%43M |
Current changes in cash | 362.50%37M | -6,133.33%-935M | 3,644.00%936M | -172.92%-262M | 217.02%298M | 0.00%8M | -87.50%-15M | 180.65%25M | -29.73%-96M | -22.31%94M |
End cash Position | 72.55%88M | 72.55%88M | 1,450.00%1.02B | 112.20%87M | 154.74%349M | 18.60%51M | 18.60%51M | 29.41%66M | -50.00%41M | -12.18%137M |
Free cash flow | -15.41%-824M | 40.94%-163M | -15.26%-370M | -171.15%-282M | 30.77%-9M | 49.04%-714M | 33.65%-276M | 45.59%-321M | 76.31%-104M | -129.55%-13M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |